Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.

about

Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.

Item

http://www.wikidata.org/entity/Q54248394

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Late therapeutic intervention ...... on in human airway epithelium.

@en

Late therapeutic intervention ...... on in human airway epithelium.

@nl

type

Item

label

Late therapeutic intervention ...... on in human airway epithelium.

@en

Late therapeutic intervention ...... on in human airway epithelium.

@nl

prefLabel

Late therapeutic intervention ...... on in human airway epithelium.

@en

Late therapeutic intervention ...... on in human airway epithelium.

@nl

P1476

Late therapeutic intervention ...... ion in human airway epithelium

@en

P2093

Amanda Davis

http://www.w3.org/2001/XMLSchema#string

Daniel W Brookes

http://www.w3.org/2001/XMLSchema#string

Heather Allen

http://www.w3.org/2001/XMLSchema#string

Ian Knowles

http://www.w3.org/2001/XMLSchema#string

John Ayrton

http://www.w3.org/2001/XMLSchema#string

Leah Daly

http://www.w3.org/2001/XMLSchema#string

Lindsey Cass

http://www.w3.org/2001/XMLSchema#string

Mark Hows

http://www.w3.org/2001/XMLSchema#string

Matthew Coates

http://www.w3.org/2001/XMLSchema#string

Pete Strong

http://www.w3.org/2001/XMLSchema#string

P2860

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate

Biochemical Effect of Resistance Mutations against Synergistic Inhibitors of RSV RNA Polymerase

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process

In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo

YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action.

Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase

Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology

Viral load drives disease in humans experimentally infected with respiratory syncytial virus

P304

2520-2534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.14221

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

175

http://www.w3.org/2001/XMLSchema#string

P50

W G Rapeport

Kazuhiro Ito

P577

2018-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29579332

http://www.w3.org/2001/XMLSchema#string

P932

5980447

http://www.w3.org/2001/XMLSchema#string